New pill targets Hard-to-Treat KRAS cancers in first human trial

NCT ID NCT07094113

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new oral drug called AMG 410, alone or with other medicines, in adults with advanced solid tumors that have KRAS gene changes. The study aims to find a safe dose and check for side effects. About 434 participants will take part across multiple dose levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AMG 410 (oral tablet), pembrolizumab (IV infusion), panitumumab (IV infusion)

What this could lead to

If successful, this could point toward a new treatment option for people with advanced cancers that have KRAS mutations, especially those who have run out of standard therapies.

What could go wrong

This is a very early Phase 1 trial, so the drug may not work or may cause serious side effects. The study is primarily looking at safety and dosing, not yet proving effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Azienda Ospedaliero Universitaria Pisana

    RECRUITING

    Pisa, 56126, Italy

  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

    RECRUITING

    Milan, 20162, Italy

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

  • Centro Ricerche Cliniche Di Verona Societa responsabilita limitata

    RECRUITING

    Verona, 37134, Italy

  • Chris OBrien Lifehouse

    RECRUITING

    Camperdown, New South Wales, 2050, Australia

  • City of Hope National Medical Center

    RECRUITING

    Duarte, California, 91010, United States

  • Duke Cancer Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Fundacion Jimenez Diaz

    RECRUITING

    Madrid, 28040, Spain

  • Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Jinan Central Hospital

    RECRUITING

    Jinan, Shandong, 250013, China

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • National Cancer Center Hospital

    RECRUITING

    Chuo-ku, Tokyo, 104-0045, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa-shi, Chiba, 277-8577, Japan

  • Next Oncology

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Next Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Princess Margaret Cancer Centre

    RECRUITING

    Toronto, Ontario, M5G 1Z5, Canada

  • Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

  • Royal Marsden Hospital

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

  • Sarah Cannon Research Institute Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Sarah Cannon Research Institute UK

    RECRUITING

    London, W1G 6AD, United Kingdom

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

  • Sir Mortimer B Davis - Jewish General Hospital

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

  • Siteman Cancer Center - Washington University

    RECRUITING

    St Louis, Missouri, 63110, United States

  • The Queen Elizabeth Hospital

    RECRUITING

    Woodville South, South Australia, 5011, Australia

  • Thomas Jefferson University

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Universitaetsklinikum Essen

    RECRUITING

    Essen, 45147, Germany

  • Universitair Medisch Centrum Utrecht

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • Universitair Ziekenhuis Antwerpen

    RECRUITING

    Edegem, 2650, Belgium

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University of California Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States